184 related articles for article (PubMed ID: 14585364)
1. Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion.
Chen HR; Ji SQ; Wang HX; Yan HM; Zhu L; Liu J; Xue M; Xun CQ
Exp Hematol; 2003 Nov; 31(11):1019-25. PubMed ID: 14585364
[TBL] [Abstract][Full Text] [Related]
2. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies.
Ji SQ; Chen HR; Yan HM; Wang HX; Liu J; Zhu PY; Xiao MH; Xun CQ
Bone Marrow Transplant; 2005 Aug; 36(4):349-54. PubMed ID: 15968293
[TBL] [Abstract][Full Text] [Related]
4. [A clinical study of haploidentical and G-CSF primed bone marrow transplantation by using CD25 for aGVHD prophylaxis].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):447-51. PubMed ID: 12513746
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
6. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
Ji SQ; Chen HR; Wang HX; Yan HM; Zhu L; Liu J; Xue M; Xun CQ
Bone Marrow Transplant; 2002 Dec; 30(12):861-6. PubMed ID: 12476277
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow].
Chen H; Ji S; Wang H
Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):760-3. PubMed ID: 11930684
[TBL] [Abstract][Full Text] [Related]
8. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
[TBL] [Abstract][Full Text] [Related]
9. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD.
Wawer A; Laws HJ; Dilloo D; Göbel U; Burdach S
Klin Padiatr; 2004; 216(3):169-75. PubMed ID: 15175962
[TBL] [Abstract][Full Text] [Related]
10. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum.
Aversa F; Tabilio A; Terenzi A; Velardi A; Falzetti F; Giannoni C; Iacucci R; Zei T; Martelli MP; Gambelunghe C
Blood; 1994 Dec; 84(11):3948-55. PubMed ID: 7524753
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1.
Ferrant A; Latinne D; Bazin H; Straetmans N; Cornet A; de la Parra B; Michaux JL
Bone Marrow Transplant; 1995 Oct; 16(4):577-81. PubMed ID: 8528175
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH
Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
[TBL] [Abstract][Full Text] [Related]
13. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
14. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Martin PJ; Pei J; Gooley T; Anasetti C; Appelbaum FR; Deeg J; Hansen JA; Nash RA; Petersdorf EW; Storb R; Ghetie V; Schindler J; Vitetta ES
Biol Blood Marrow Transplant; 2004 Aug; 10(8):552-60. PubMed ID: 15282533
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies.
Kircher B; Lätzer K; Gastl G; Nachbaur D
Clin Exp Immunol; 2003 Dec; 134(3):426-30. PubMed ID: 14632747
[TBL] [Abstract][Full Text] [Related]
17. Myeloablative haploidentical hematopoietic stem cell transplantation using basiliximab for graft-versus-host disease prophylaxis.
Huang R; Tu S; Deng L; Kang Q; Song C; Li Y
Hematology; 2015 Jul; 20(6):313-9. PubMed ID: 25321657
[TBL] [Abstract][Full Text] [Related]
18. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Hale G; Zhang MJ; Bunjes D; Prentice HG; Spence D; Horowitz MM; Barrett AJ; Waldmann H
Blood; 1998 Dec; 92(12):4581-90. PubMed ID: 9845524
[TBL] [Abstract][Full Text] [Related]
19. [Clinical investigation on treatment of children leukemia with non-T-cell depleted haploidentical bone marrow transplantation].
Yan HM; Ji SQ; Chen HR; Duan LN; Zhu L; Liu J; Xue M; Ding L; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):101-5. PubMed ID: 18315910
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients.
Blaise D; Olive D; Hirn M; Viens P; Lafage M; Attal M; Stoppa AM; Gabert J; Gastaut JA; Camerlo J
Bone Marrow Transplant; 1991 Aug; 8(2):105-11. PubMed ID: 1933050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
